Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,321 public trials 2,836 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

NCT06494878

Conditions
Aspirin, Cardiovascular Diseases, Embolism, +26 more
Locations
  • Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann Brussels, Belgium
  • Foothills Medical Centre Calgary, Alberta, Canada
  • The Ottawa Hospital - General Campus Ottawa, Ontario, Canada
  • Hvidovre Hospital Hvidovre, Capital Region, Denmark
View Trial Details
Recruiting

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

NCT07549516

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Novartis Investigative Site Baden-Baden, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidenheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Schwäbisch Hall, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
View all 54 locations
View Trial Details
Recruiting

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06158841

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham - Main /ID# 261434 Birmingham, Alabama, United States
  • Mayo Clinic Hospital - Phoenix /ID# 263326 Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center for Research /ID# 261438 Berkeley, California, United States
  • Providence - St. Jude Medical Center /ID# 262031 Fullerton, California, United States
View all 166 locations
View Trial Details
Recruiting

TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

NCT03816319

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • VCU Massey Comprehensive Cancer Center Richmond, Virginia, United States
View Trial Details
Recruiting

Cooperative Assessment of Late Effects for SCD Curative Therapies

NCT05153967

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details

Related conditions